SEC Form 4 · accession 0001493152-26-039746
PALISADE BIO, INC. · PALI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John David Finley
Officer — CEO, CFO · Director
Period of report
Aug 19, 2026
Accepted (ET)
Aug 21, 2026 · 6:26 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001357459
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 19, 2026 | G | 88,400 | $0.00 | D | 129,288 | D | |
| Common Stock | Aug 19, 2026 | G | 88,400 | $0.00 | A | 88,451 | I | By FCW Investments, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Reporting Person transferred these shares to FCW Investments, LLC. The Reporting Person is the managing member of FCW Investments, LLC and has the sole investment and voting power over the securities held by this entity.